These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 33615463)

  • 41. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Possibilities of bacteriophage therapy].
    Skurnik M; Kiljunen S
    Duodecim; 2016; 132(8):712-9. PubMed ID: 27244930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacteriophage therapy for infections in CF.
    Chan BK; Stanley G; Modak M; Koff JL; Turner PE
    Pediatr Pulmonol; 2021 Feb; 56 Suppl 1():S4-S9. PubMed ID: 33434411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bacteriophage Therapy: Retrospective Review and Future Prospects].
    Tian EK; Wang Y; Wu ZX; Wan ZQ; Cheng W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):170-175. PubMed ID: 33829687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phage therapy of wound-associated infections.
    Zyman A; Górski A; Międzybrodzki R
    Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunophage synergy is required for successful pulmonary phage therapy].
    De Jode M; Roach D; Debarbieux L
    Med Sci (Paris); 2018 Apr; 34(4):291-293. PubMed ID: 29658466
    [No Abstract]   [Full Text] [Related]  

  • 48. [Phage therapy: a realistic weapon against multidrug resistant bacteria].
    Dufour N; Debarbieux L
    Med Sci (Paris); 2017 Apr; 33(4):410-416. PubMed ID: 28497737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen.
    Roach DR; Leung CY; Henry M; Morello E; Singh D; Di Santo JP; Weitz JS; Debarbieux L
    Cell Host Microbe; 2017 Jul; 22(1):38-47.e4. PubMed ID: 28704651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
    Squires RA
    N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy.
    Fujiki J; Nakamura K; Nakamura T; Iwano H
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological limitations of phage therapy.
    Nilsson AS
    Ups J Med Sci; 2019 Nov; 124(4):218-227. PubMed ID: 31724901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
    Torres-Barceló C
    Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
    Furfaro LL; Payne MS; Chang BJ
    Front Cell Infect Microbiol; 2018; 8():376. PubMed ID: 30406049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy.
    Sheam MM; Syed SB; Nain Z; Tang SS; Paul DK; Ahmed KR; Biswas SK
    J Chemother; 2020 Dec; 32(8):395-410. PubMed ID: 32820711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.